z-logo
open-access-imgOpen Access
Drug induced oral erythema multiforme
Author(s) -
Shaik Mohamed Asif,
Shaik Mohamed Shamsudeen,
Khalil Ibrahim Assiri,
Hussain Mohammed Al Muburak,
Sultan Mohammed Kaleem,
Abdul Ahad Khan,
Mansoor Shariff
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000022387
Subject(s) - medicine , erythema multiforme , dermatology , erythema , drug , prednisolone , oral mucosa , surgery , pathology , pharmacology
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations. Patient concerns: This article presents 2 case reports of Oral erythema multiforme in which drugs were the precipitating factor. Its etiopathogenesis, differential diagnosis and treatment modalities of the disease is discussed. Diagnosis: Based on patient's complaints, drug history and clinical appearance, provisional diagnosis of drug induced erythema multiforme was considered. Intervention: For case 1, patient was instructed to discontinue usage of drug and prescribed systemic steroid (Prednisolone 10 mg/d) for a week along with germicidal drugs to prevent secondary infection. Medication was tapered to 5 mg/d after first week. For case 2, patient was instructed to discontinue the drug and systemic steroid prednisolone 20 mg /d for 1 week with tapering dose of 10 mg/d for the second week was administered. Outcome: For case 1 and case 2 healing of the lesions were evident on third week of follow up. Conclusion: Medications should be taken under medical supervision. Over the counter drugs might lead to allergic reactions like drug induced oral erythema multiforme, which is a rare variant and needs to be differentiate from other oral ulcerative lesion for prompt management and follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here